Corinne Epperly - 12 Jun 2024 Form 4 Insider Report for IN8BIO, INC. (INAB)

Reporting relationship: Director
Issuer ticker: INAB
Reported as of: 12 Jun 2024
Net transaction value: $0
SEC form: 4
Accepted by SEC: 14 Jun 2024, 17:00:11 UTC
Prior SEC filing: 08 Feb 2024
Next SEC filing: 23 Dec 2024
Source filing: View source filing
Reporting owner signature: /s/ Jason Minio, Attorney-in-Fact

Key filing fact

Corinne Epperly filed Form 4 for IN8BIO, INC. (INAB) on 14 Jun 2024.

Key facts

This page summarizes Corinne Epperly's Form 4 filing for IN8BIO, INC. (INAB).
1 reported transaction and 1 derivative row are listed below.
Accepted by SEC: 14 Jun 2024, 17:00.

Change

Previous filing in this sequence was filed on 08 Feb 2024.
Current net transaction value: $0.

Research use

This tells you what this filing adds before you inspect full transaction and derivative tables.
You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reported derivative securities

Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.

INAB transaction Derivative

Stock Option (right to buy)

Award

Transaction value: $0
Shares: +33,650
Change %
Price: $0.000000
Shares after: 33,650
Date: 12 Jun 2024
Ownership: Direct
Underlying class: Common Stock
Underlying amount: 33,650
Exercise price: $1.47
Footnotes: F1

^* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 1 footnote

Footnote F1

One twelfth (1/12th) of the shares subject to the option shall vest in equal monthly installments commencing on July 12, 2024; provided, however, that the option will in any case be fully vested on the date of the Company's next annual meeting of stockholders, subject to the Reporting Person continuing to provide service through each such date.